1887

Abstract

Infections with human herpesviruses share several molecular characteristics, but the diversified medical outcomes are distinct to viral subfamilies and species. Notably, both clinical and molecular correlates of infection are a challenging field and distinct patterns of virus–host interaction have rarely been defined; this study therefore focuses on the search for virus-specific molecular indicators. As previous studies have demonstrated the impact of herpesvirus infections on changes in host signalling pathways, we illustrate virus-modulated expression levels of individual cellular protein kinases. Current data reveal (i) α-, β- and γ-herpesvirus-specific patterns of kinase modulation as well as (ii) differential levels of up-/downregulated kinase expression and phosphorylation, which collectively suggest (iii) defined signalling patterns specific for the various viruses (VSS) that may prove useful for defining molecular indicators. Combined, the study confirms the correlation between herpesviral replication and modulation of signalling kinases, possibly exploitable for the characterization of viral infections.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001370
2020-01-20
2020-02-28
Loading full text...

Full text loading...

References

  1. Whitley R, Baines J. Clinical management of herpes simplex virus infections: past, present, and future. F1000. Research 2018;7:
    [Google Scholar]
  2. Carney WP, Hirsch MS. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis 1981;144:47–54 [CrossRef]
    [Google Scholar]
  3. Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol 2015;235:288–297 [CrossRef]
    [Google Scholar]
  4. Jha H, Banerjee S, Robertson E. The role of Gammaherpesviruses in cancer pathogenesis. Pathogens 2016;5:18 [CrossRef]
    [Google Scholar]
  5. Falcinelli SD, Chertow DS, Kindrachuk J. Integration of global analyses of host molecular responses with clinical data to evaluate pathogenesis and advance therapies for emerging and re-emerging viral infections. ACS Infect Dis 2016;2:787–799 [CrossRef]
    [Google Scholar]
  6. Oberstein A, Perlman DH, Shenk T, Terry LJ. Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome. Proteomics 2015;15:2006–2022 [CrossRef]
    [Google Scholar]
  7. Hutterer C, Wandinger SK, Wagner S, Müller R, Stamminger T et al. Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, Abl and AMPK. Antiviral Res 2013;99:139–148 [CrossRef]
    [Google Scholar]
  8. Feichtinger S, Stamminger T, Müller R, Graf L, Klebl B et al. Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1. J Gen Virol 2011;92:1519–1531 [CrossRef]
    [Google Scholar]
  9. Graf L, Webel R, Wagner S, Hamilton ST, Rawlinson WD et al. The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins. Viruses 2013;5:3213–3230 [CrossRef]
    [Google Scholar]
  10. Steingruber M, Socher E, Hutterer C, Webel R, Bergbrede T et al. The interaction between cyclin B1 and cytomegalovirus protein kinase pUL97 is determined by an active kinase domain. Viruses 2015;7:4582–4601 [CrossRef]
    [Google Scholar]
  11. Graf L, Feichtinger S, Naing Z, Hutterer C, Milbradt J et al. New insight into the phosphorylation-regulated intranuclear localization of human cytomegalovirus pUL69 mediated by cyclin-dependent kinases (CDKs) and viral CDK orthologue pUL97. J Gen Virol 2016;97:144–151 [CrossRef]
    [Google Scholar]
  12. Steingruber M, Kraut A, Socher E, Sticht H, Reichel A et al. Proteomic interaction patterns between human cyclins, the cyclin-dependent kinase ortholog pUL97 and additional cytomegalovirus proteins. Viruses 2016;8:219 [CrossRef]
    [Google Scholar]
  13. Steingruber M, Keller L, Socher E, Ferre S, Hesse A-M et al. Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97. J Biol Chem 2019;294:6188–6203 [CrossRef]
    [Google Scholar]
  14. Hertel L, Chou S, Mocarski ES. Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog 2007;3:e6 [CrossRef]
    [Google Scholar]
  15. Milbradt J, Hutterer C, Bahsi H, Wagner S, Sonntag E et al. The prolyl isomerase Pin1 promotes the Herpesvirus-Induced phosphorylation-dependent disassembly of the nuclear lamina required for nucleocytoplasmic egress. PLoS Pathog 2016;12:e1005825 [CrossRef]
    [Google Scholar]
  16. Marschall M, Muller YA, Diewald B, Sticht H, Milbradt J. The human cytomegalovirus nuclear egress complex unites multiple functions: recruitment of effectors, nuclear envelope rearrangement, and docking to nuclear capsids. Rev Med Virol 2017;27:e1934 [CrossRef]
    [Google Scholar]
  17. Terry LJ, Vastag L, Rabinowitz JD, Shenk T. Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. Proc Natl Acad Sci USA 2012;109:3071–3076 [CrossRef]
    [Google Scholar]
  18. Hutterer C, Eickhoff J, Milbradt J, Korn K, Zeitträger I et al. A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations. Antimicrob Agents Chemother 2015;59:2062–2071 [CrossRef]
    [Google Scholar]
  19. Scherer M, Schilling EM, Stamminger T. The human CMV IE1 protein: an offender of PML nuclear bodies. Adv Anat Embryol Cell Biol 2017;223:77–94 [CrossRef]
    [Google Scholar]
  20. Kalejta RF. Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev 2008;72:249–265 [CrossRef]
    [Google Scholar]
  21. Biolatti M, Dell'Oste V, Pautasso S, von Einem J, Marschall M et al. Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability. J Virol 2016;90:8238–8250 [CrossRef]
    [Google Scholar]
  22. Kas-Deelen AM, The TH, Blom N, van der Strate BW, De Maar EF et al. Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells mediated by phagocytosis and cell fusion?. Intervirology 2001;44:8–13 [CrossRef]
    [Google Scholar]
  23. Barabas S, Spindler T, Kiener R, Tonar C, Lugner T et al. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity. BMC Immunol 2017;18:14 [CrossRef]
    [Google Scholar]
  24. Ruzsics Z, Lemnitzer F, Thirion C. Engineering adenovirus genome by bacterial artificial chromosome (BAC) technology. Methods Mol Biol 2014;1089:143–158 [CrossRef]
    [Google Scholar]
  25. Kiener R, Fleischmann M, Schwegler C, Ruzsics Z, Thirion C et al. Vaccine vectors based on adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo. Sci Rep 2018;8:1474 [CrossRef]
    [Google Scholar]
  26. Sonntag E, Hamilton ST, Bahsi H, Wagner S, Jonjic S et al. Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components. J Gen Virol 2016;97:1676–1685 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001370
Loading
/content/journal/jgv/10.1099/jgv.0.001370
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error